Assessing the Effects of Cool Roofs on Indoor Environments and Health in Hermosillo, Mexico
Launched by ADITI BUNKER · Feb 13, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of cool roofs—special coatings that reflect sunlight—to see if they can help improve health and comfort indoors in Hermosillo, Mexico, where temperatures have been extremely high. The trial aims to find out if these cool roofs can lower indoor temperatures, reduce health issues like high blood pressure and depression, and improve overall well-being for those living in hot conditions. This is especially important for people living in poorer housing who are more vulnerable to heat.
To participate in the trial, you must be a permanent resident of a household in Hermosillo. However, if your roof is damaged or unstable, or if you cannot give your consent, you won't be able to join. While the trial has not yet started recruiting participants, those who do take part can expect to help researchers understand how cool roofs can make homes more comfortable and safer during extreme heat. This is a crucial step in finding ways to help communities adapt to rising temperatures due to climate change.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Permanent household resident.
- Exclusion Criteria:
- • Roof damage, inaccessible or instability of roof adversely affecting cool roof coating application.
- • Participant unable to provide written/verbal informed consent.
About Aditi Bunker
Aditi Bunker is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on optimizing trial design and execution, Aditi Bunker collaborates with leading healthcare professionals and research institutions to facilitate the development of safe and effective therapies. The organization emphasizes ethical practices, rigorous data management, and patient-centered approaches, ensuring that all trials adhere to the highest standards of quality and compliance. Through its strategic partnerships and commitment to scientific excellence, Aditi Bunker aims to contribute significantly to the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hermosillo, Sonora, Mexico
Patients applied
Trial Officials
Collin Tukuitonga, Sir. Dr.
Principal Investigator
University of Auckland, New Zealand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported